Arkolith/Insider Trading/KIN/Form 4

Chin Richard

Chief Executive Officer, DirectorKindred Biosciences, Inc. (KIN) · full profile →Form 4 · filed Aug 4, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$368K
Net Open-Market Flow
-$368K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 2, 2021Sell(S)40K$9.21$368K1.5M
Jul 22, 2021Gift(G)320K—$01.6M

Transaction Codes

S
Open-market sale
G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001250853-21-000081) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML